Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
McKinsey
Moodys
Colorcon
McKesson

Last Updated: August 19, 2022

Sodium polystyrene sulfonate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for sodium polystyrene sulfonate and what is the scope of patent protection?

Sodium polystyrene sulfonate is the generic ingredient in five branded drugs marketed by Kvk Tech, Concordia, Ani Pharms, Belcher, Biopharm, Chartwell Rx, Citrusphrma, Cmp Pharma Inc, Epic Pharma Llc, Nuvo Pharms Inc, Pai Holdings Pharm, Hikma, Morton Grove, and Roxane, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for sodium polystyrene sulfonate. Twelve suppliers are listed for this compound.

Drug Prices for sodium polystyrene sulfonate

See drug prices for sodium polystyrene sulfonate

Recent Clinical Trials for sodium polystyrene sulfonate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, IrvinePhase 4
Tris Pharma, Inc.Phase 4
The Rogosin InstitutePhase 4

See all sodium polystyrene sulfonate clinical trials

US Patents and Regulatory Information for sodium polystyrene sulfonate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nuvo Pharms Inc SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 204071-002 Nov 28, 2014 RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Pai Holdings Pharm SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 088786-001 Sep 11, 1984 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Citrusphrma SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 040909-001 Dec 3, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Kvk Tech KALEXATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 040905-001 Mar 30, 2009 AA RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Nuvo Pharms Inc SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 204071-001 Nov 28, 2014 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Harvard Business School
Moodys
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.